Cefix (cefixime) is a
semisynthetic, cephalosporin antibiotic for oral administration.
Cefix (cefixime) is indicated in the treatment of the following
Uncomplicated urinary tract infections: caused by Escherichia coli and
Otitis media: Caused by Haemophilus influenzae (beta-lactamase positive
and negative strains), Moraxella (Branhamella) catarrhalis (most of
which are beta-lactamase positive) and Streptococcus pyogenes.
Pharyngitis and tonsillitis: Caused by S. pyogenes.
Cefix is generally effective in the eradication of S. pyogenes
from the nasopharynx.
Acute bronchitis and acute exacerbations of chronic bronchitis: Caused
by S. pneumoniae and H. influenzae (beta-lactamase positive and negative
Uncomplicated gonorrhea (cervical/urethral): Caused by Neisseria
gonorrhoeae (penicillinase- and non–penicillinase-producing strains).
Aleppo Pharmaceutical Company (ALPHA) is Syria's leading
manufacturer and distributor of pharmaceutical products. Providing high
quality products according to GMP requirements; regulations and ISO 9002
(Quality Management System).
Syrian Pharmaceutical Industries, Middle East, Syria Pharmaceutical
Industry, pharmacy, Medicaments, medical, Drugs, arab pharmaceutical
manufacturing, pharmaceutical companies, pharmaceutical sales.
If you have any questions about Cefix that have not been
answered on this site send us an email or call ALPHA Pharmaceutical
Industry at + 963-21-2122424.
Copyright © ALPHA – Aleppo Pharmaceutical Industries, Aleppo-Syria -
Cefix. All rights reserved
Web Design by
Syrian Web Solutions